Crispr Therapeutics

Interest rates may finally be moderating. Now what?

By Garvin Jabusch. After raising interest rates an unprecedented 21-fold (from a target range of 0%-0.25% in March of 2022, to 5.25%-5.50% since last July) [...]

Let’s Talk Volatility ~ Audio Recording

Today we offer you an audio companion piece to our CIO's recent blog titled "Let's Talk Volatility," because there are so many misconceptions and outdated [...]